Vaccines Market Size and Forecasts (2020 – 2030)

Vaccines Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit & Conjugate Vaccines, and Others), Technology [Recombinant Vaccines, mRNA Vaccines, Cell-Based Vaccines, Virus-Like Particles (VLPs), and Others], Application (Human Papillomavirus, Cancer, MMR, DPT, and Others), Route of Administration (Oral, Injectable, and Nasal), Age (Pediatric Vaccine and Adult Vaccine), End User (Healthcare Facilities, Vaccination Programs and Centers, and Others),(and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Send Enquiry
Item ID: TIPRE00015468 Category: Tags: , ,

$3,633$6,433

Description

The vaccines market is expected to grow from US$ 135.28 billion in 2022 to US$ 216.30 billion by 2030; it is expected to grow at a CAGR of 6.0% from 2022 to 2030. Rising prevalence of infectious diseases and an increase for uptake of vaccines amid the COVID-19 pandemic are a few factors driving the vaccines market growth.
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. A vaccine typically preparation contains an agent responsible for resembling a disease-causing microorganism and is often made from a weakened or killed form of the microbe, toxin, or one of its surface proteins. Vaccines can be prophylactic or therapeutic, offering immunity.
Market Opportunity
Therapeutic Vaccine Development
Traditional vaccines stimulate the production of antibodies and immune proteins that target specific pathogens like viruses and bacteria. Likewise, therapeutic vaccines stimulate the immune system to target cancer cells and control the progression of chronic infections like HIV. Further, therapeutic vaccines typically stimulate the recipient’s immune system to slow or stop chronic disease progression or target cancer cells. Further, therapeutic vaccines for the treatment of noninfectious diseases encompass a wide variety of possible formulations, antigens, and mechanism of action. Therefore, therapeutic vaccines development will provide lucrative market opportunity for the forecast period 2022-2030.

Examples of Therapeutic Vaccines in Development
Indication Development Phase
Ovarian Cancer Phase 1
Multiple Myeloma Phase 1
Type 1 Diabetes Preclinical
Acute Myelogenous Leukemia 3
Mesothelioma 2
Source: TheInsight Partners Analysis
?
Market Insights
Rising Infectious Diseases
According to the Connecticut Department of Public Health report 2020, below are the infectious diseases recorded in 2020 in Connecticut.
Reported Cases of Connecticut Reportable Diseases in 2020
Disease Total
Hepatitis A 15
Influenza 98
Malaria 4
Tuberculosis 54
SARS-CoV-2 2,00,379
Source: TheInsight Partners Analysis

Additionally, the below table reveals notable infectious disease by the Center for Health Protection report in 2020:

Notable Infectious Disease
Disease Total
SARS-CoV-2 8847
Chickenpox 1987
Community-associated methicillin-resistant Staphylococcus aureus infection 813
Dengue Fever 22
Tuberculosis 3656
Source: TheInsight Partners Analysis
Among all the infectious diseases, SARS-CoV-2 was all time high during 2020 to 2022 period where other uptake of vaccines including Dengue, Chickenpox, Tuberculosis, and others were low. However, SARS-CoV-2 vaccines uptake was all time high due to rising cases globally. According to the Public Health England report published in 2021, 12-month UK coverage for DTaP/IPV/Hib/HepB3 vaccination increased by 0.1% to 92.2% and Rotavirus by 0.3% to 90.6%. However, MenB2 decreased by 0.1, accounting for 92.3% compared to the previous year. Also, the NHS England report reveals that, in December 2022, a total of 88.9 of all adult care home residents had been vaccinated with a COVID-19 booster dose. Therefore, rising prevalence of infectious diseases, demand for vaccination is high resulting in overall market growth for the forecast period 2022-2030.
Type-Based Insights
Based on type, the vaccines market is segmented as live attenuated vaccines, inactivated vaccines, toxoid vaccines, subunit & conjugate vaccines, and others. The live attenuated vaccines segment held the largest market share in 2022. Live attenuated vaccines are very effective vaccines used in the prevention of a variety of diseases, including influenza, chickenpox, measles, polio, and tuberculosis. As per the World Health Organization (WHO) report, there are around a billion cases of seasonal influenza, including 5 million cases of severe illness. Also, it causes around 290,000 to 650,000 respiratory deaths annually. Therefore, live-attenuated influenza vaccine (LAIV) proves advantageous to combat the infection among the population. For example, LAIV can provide upto 90% protection among adults under 65 years of age and upto 40% of adults over 65. The aforementioned factors are responsible for influential segment growth for the forecast period 2022-2030.
Based on application, the vaccines market is segregated into Human Papillomavirus (HPV), cancer, MMR, DPT, and others. The HPV segment held the largest market share in 2022. According to the WHO report, HPV is highly prevalent among women in Sub-Saharan Africa (24%), followed by Latin America and the Caribbean (16%), Eastern Europe (14%), and South-East Asia (14%). Also, 625,600 women and 694,000 men have HPV-related cancer annually globally. Also, in 2020, cervical cancer accounted for 93% of HPV-related cancers among women. Therefore, there is a high demand for HPV vaccines among the population due to rising prevalent cases, as these vaccines protect against genital warts and most cases of cervical cancer. Also, HPV vaccines are highly approved by the US Food and Drug Administration (USFDA). “GARDASIL 9” is one such example of an HPV vaccine approved by the US FDA. The aforementioned factors are responsible for influential segment growth for the forecast period 2022-2030.
Route of Administration-Based Insights
In terms of route of administration, the vaccines market is categorized as oral, nasal, and injectable. The injectable segment held a larger share of the market in 2022. The most common route of vaccine administration is through the injectable route, as administering a vaccine through a subcutaneous or intradermal route may cause local irritation, skin discoloration, inflammation, and many more.
Further, the CDC report reveals that DTaP, DT, HepA, HepB, Hib, HPV, IIV4, RIV4, ccIIV4, IPV*†, MenACWY, MenB, MMR‡ , PCV13, PPSV23*†, RZV, Td, Tdap, TT, VAR† are common vaccines administered through the injectable route of administration. Varied vaccines administered through injectable routes act as a standalone factor responsible for influential segment growth for the forecast period 2022-2030.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

In progress

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Cement Board Market, by Product Type
1.3.2 South & Central America Cement Board Market, by Application
1.3.3 South & Central America Cement Board Market, by End-Use
1.3.4 South & Central America Cement Board Market, by Country
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis formulation:
3.2.4 Macro-economic factor analysis:
3.2.5 Developing base number:
3.2.6 Data Triangulation:
3.2.7 Country level data:
4. South & Central America Cement Board Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants:
4.2.2 Bargaining Power of Buyers:
4.2.3 Bargaining Power of Suppliers:
4.2.4 Competitive Rivalry:
4.2.5 Threat of Substitutes:
4.3 Ecosystem Analysis
4.3.1 Raw Material:
4.3.2 Manufacturers:
4.3.3 Distributors or Suppliers:
4.3.4 End-Use Industries
4.4 Expert Opinion
5. South & Central America Cement Board Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Cement Board in Construction Sector
5.1.2 Upsurge in Demand for Energy-Efficient Buildings
5.2 Market Restraints
5.2.1 High Cost of Installation
5.3 Market Opportunities
5.3.1 Rising Urbanization in Emerging Economies
5.4 Future Trends
5.4.1 Increasing Adoption of Eco-Friendly Construction Materials
5.5 Impact Analysis
6. Cement Board – South & Central America Market Analysis
6.1 South & Central America Cement Board Market Overview
6.2 South & Central America Cement Board Market -Volume and Forecast to 2028 (Million Square Meters)
6.3 South & Central America Cement Board Market -Revenue and Forecast to 2028 (US$ Million)
7. South & Central America Cement Board Market Analysis – By Product Type
7.1 Overview
7.2 South & Central America Cement Board Market, By Product Type (2021 and 2028)
7.3 Fiber Cement Board
7.3.1 Overview
7.3.2 Fiber Cement Board: South & Central America Cement Board Market – Volume and Forecast to 2028 (Million Square Meters)
7.3.3 Fiber Cement Board: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Cement Bonded Particle Board
7.4.1 Overview
7.4.2 Cement Bonded Particle Board: South & Central America Cement Board Market – Volume and Forecast to 2028 (Million Square Meters)
7.4.3 Cement Bonded Particle Board: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Cement Board Market Analysis – By Application
8.1 Overview
8.2 South & Central America Cement Board Market, By Application (2021 and 2028)
8.3 Roofing
8.3.1 Overview
8.3.2 Roofing: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outside Siding or Façade
8.4.1 Overview
8.4.2 Outside Siding or Façade: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Cement Board Market Analysis – By End-Use
9.1 Overview
9.2 South & Central America Cement Board Market, By End-Use (2021 and 2028)
9.3 Residential
9.3.1 Overview
9.3.2 Residential: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Non-Residential
9.4.1 Overview
9.4.2 Non-Residential: South & Central America Cement Board Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Cement Board Market – Country Analysis
10.1 Overview
10.1.1 South & Central America: South & Central America Cement Board Market, by Key Country
10.1.1.1 Brazil: South & Central America Cement Board Market -Volume and Forecast to 2028 (Million Square Meters)
10.1.1.2 Brazil: South & Central America Cement Board Market -Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Brazil: South & Central America Cement Board Market, by Product Type
10.1.1.2.2 Brazil: South & Central America Cement Board Market, by Product Type
10.1.1.2.3 Brazil: South & Central America Cement Board Market, by Application
10.1.1.2.4 Brazil: South & Central America Cement Board Market, by End-Use
10.1.1.3 Argentina: South & Central America Cement Board Market -Volume and Forecast to 2028 (Million Square Meters)
10.1.1.4 Argentina: South & Central America Cement Board Market -Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Argentina: South & Central America Cement Board Market, by Product Type
10.1.1.4.2 Argentina: South & Central America Cement Board Market, by Product Type
10.1.1.4.3 Argentina: South & Central America Cement Board Market, by Application
10.1.1.4.4 Argentina: South & Central America Cement Board Market, by End-Use
10.1.1.5 Rest of South & Central America: South & Central America Cement Board Market -Volume and Forecast to 2028 (Million Square Meters)
10.1.1.6 Rest of South & Central America: South & Central America Cement Board Market -Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Rest of South & Central America: South & Central America Cement Board Market, by Product Type
10.1.1.6.2 Rest of South & Central America: South & Central America Cement Board Market, by Product Type
10.1.1.6.3 Rest of South & Central America: South & Central America Cement Board Market, by Application
10.1.1.6.4 Rest of South & Central America: South & Central America Cement Board Market, by End-Use
11. Industry Landscape
11.1 Overview
11.2 New Product Development
11.3 Partnership and Expansion
11.4 Merger and Acquisition
12. Company Profiles
12.1 Swisspearl Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Soben International Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 SCG Building Materials Co., Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Etex NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Compagnie de Saint Gobain SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

In progress
In progress

The List of Companies – Vaccines Market
– GSK
– Pfizer
– Sanofi
– Merck
– Serum Institute of India (SII)
– AstraZeneca
– BioNTech
– Biological E
– Sinovac
– Sinopharm
– Bharat Biotech

Reviews

There are no reviews yet.

Be the first to review “Vaccines Market Size and Forecasts (2020 – 2030)”